A Post-marketing Surveillance Study of Beyfortus (Nirsevimab) in Republic of Korea

Clinical trial NCT07200206 · RECRUITING

Trial details

NCT number: NCT07200206
Sponsor: Sanofi
Status: RECRUITING
Study type: OBSERVATIONAL

Respiratory Syncytial Virus

Start date: 2025-10-02
Primary completion: 2029-09-26
Enrollment: 3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.